Actinidia arguta supplementation protects aorta and liver in rats with induced hypercholesterolemia.
Nutr Res. 2016 11 ;36(11):1231-1242. Epub 2016 Sep 30. PMID: 27865618
There are no published results focusing on the study of hardy kiwifruit as a supplementation to the atherogenic diet. We hypothesized that hardy kiwifruit (Actinidia arguta (A. arguta)) from Poland possess better pro-healthy action than two Asian varieties (Hayward and Bidan). We tested this hypothesis by measuring the metabolic reactions of rats loaded with 1% cholesterol and supplemented with 5% of hardy kiwifruit (A. arguta), Hayward, or Bidan in their diets. The experiment was performed on 71 male Wistar rats. Cholesterol showed a significant impact on the rise of liver somatic index, while lipid profile improved by decreasing the levels of TC, LDL-C, TC/HDL-C, AI, TG, and increasing HDL-C in the serum of rats (P<.05). Total plasma antioxidant capacity determined by ABTS, FRAP, and DPPH assays was increased. ALP in rat serum was higher in groups receiving cholesterol diets and kiwifruit. A decrease in fibrinogen as well as prolonged prothrombin time and a reduction of the MPO in serum were estimated. The smallest percentage of lesions in the aortic arch was in the ChGeneva, ChWeiki, and ChAnna. Similarly, the smallest fatty liver disease was recorded in the ChGeneva and ChAnna groups. The distribution of lipids in the liver from these groups had a character of"mosaic,"in hardy/mini kiwifruit (Jumbo), Hayward, and Bidan was distributed uniformly. The longest villi were in ChWeiki, and significantly lower in ChHayward and ChBidan. The present results support our hypothesis that A. arguta showed better pro-health impacts in rats loaded with cholesterol than Hayward and Bidan kiwifruit, and, for the first time, the positive nutritional effects of supplemented A. arguta for hypercholesterolemia are noted.